Trial Profile
A Cross-Over Comparative Study of Inhaled Mannitol, Alone and in Combination With Daily rhDNase, in Children With Cystic Fibrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jan 2024
Price :
$35
*
At a glance
- Drugs Mannitol (Primary) ; Dornase alfa
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Pharmaxis; Syntara Limited
- 04 Dec 2023 According to a Syntara Limited media release, Pharmaxis has changed its name to Syntara Limited
- 30 Mar 2009 New trial record